Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
antisense oligonucleotide
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
1
×
boston top stories
clinical trials
columbia university
david goldstein
depression
epi4k
epilepsy
essential tremor
1
×
investing
kiran reddy
life sciences
major depressive disorder
marcio souza
national blog main
national top stories
new york blog main
new york top stories
1
×
perimenopausal depression
praxis precision medicines
ptc therapeutics
startups
steven petrou
third rock ventures
university of melbourne
1
×
venture capital
What
aims
backed
cause
ceo
drugs
epilepsy
genes
genetic
links
marcio
1
×
medicines
mutations
neuro
new
praxis
precision
research
souza
stop
turn
Language
unset
1
×
Current search:
marcio
×
unset
×
" new york top stories "
×
" essential tremor "
×
" boston blog main "
×
" university of melbourne "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs